New Jersey 2022-2023 Regular Session

New Jersey Senate Bill S3176

Introduced
10/3/22  
Refer
10/3/22  
Report Pass
11/3/22  
Refer
11/3/22  
Report Pass
1/4/24  
Engrossed
1/8/24  
Enrolled
1/8/24  
Chaptered
1/16/24  

Caption

Requires DEP and Drinking Water Quality Institute to perform study concerning regulation and treatment of perfluoroalkyl and polyfluoroalkyl substances.

Impact

The implications of S3176 resonate deeply within the context of environmental health and state regulatory practices. By demanding a systematic study on PFAS regulation, the bill seeks to enhance the understanding of these complex chemical compounds notorious for their environmental persistence and adverse health effects. With PFAS linked to various health risks, including cancer, the findings of this study could pave the way for updated regulations that prioritize public safety and environmental protection.

Summary

Senate Bill S3176, introduced in New Jersey, mandates the Department of Environmental Protection (DEP) and the Drinking Water Quality Institute to conduct a comprehensive study on the regulation and treatment of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in drinking water. This study aims to assess the feasibility of establishing maximum contaminant levels, either for the entire class of PFAS or for specific subclasses or mixtures rather than for individual substances. Additionally, the bill mandates an evaluation of treatment technologies capable of removing PFAS from both drinking water and wastewater.

Contention

Notable points of contention may arise concerning the pace of regulatory change and the implications for businesses that utilize PFAS in their products. Opponents of stringent regulations might argue that such measures could increase operational costs and limit the availability of certain products. Conversely, advocates for public health may argue for quicker action to mitigate the risks associated with PFAS exposure. The outcomes from the DEP study are likely to impact both state laws and industry standards significantly.

Additional_information

S3176 emphasizes the importance of data-driven decision-making in environmental policy. The bill requires the DEP to publish its findings within 24 months, ensuring transparency and accountability in the outreach to the legislature and the public. As PFAS is a broad category with ongoing developments in research and regulation, the study's outcome will be critical in shaping future strategies for managing water quality and environmental safety concerning these substances.

Companion Bills

NJ A4760

Same As Requires DEP and Drinking Water Quality Institute to perform study concerning regulation and treatment of perfluoroalkyl and polyfluoroalkyl substances.

Previously Filed As

NJ S3835

Requires DEP to perform certain assessments concerning regulation of perfluoroalkyl and polyfluoroalkyl substances.

NJ A3113

Requires DEP to perform certain assessments concerning regulation of perfluoroalkyl and polyfluoroalkyl substances.

NJ S1224

Requires DEP to study feasibility of using alternative water supply source when perfluoroalkyl or polyfluoroalkyl substances exceed maximum contaminant level.

NJ S1222

Requires public water systems and landlords to provide certain notice of elevated perfluoroalkyl or polyfluoroalkyl substances levels in drinking water; requires DEP to establish educational program.

NJ SB1313

Drinking water: perfluoroalkyl and polyfluoroalkyl substances.

NJ S2266

Limits regulated perfluoroalkyl and polyfluoroaklyl substances from menstrual products.

NJ S1230

Perfluoroalkyl and Polyfluoroalkyl Substances

NJ S1221

"Protecting Against Forever Chemicals Act"; establishes requirements, prohibitions, and programs for regulation of perfluoroalkyl and polyfluoroalkyl substances (PFAS).

NJ H1019

Perfluoroalkyl and Polyfluoroalkyl Substances

NJ S1251

Requires certain water purveyors to identify, and use, alternative water supply source when perfluoralkyl or polyfluoroalkyl substances exceed maximum contaminant levels.

Similar Bills

CA AB1612

Disposition of controlled substances.

MA H2227

Replacing archaic and stigmatizing language for substance use

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1203

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.

NJ S2271

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.